Wegovy

Page 6 of 6

Ozempic manufactured by Novo Nordisk packaging on December 7, 2023.
Health

Novo Nordisk became Europe’s most valuable company with the rise of Wegovy and Ozempic, but it’s facing stiff competition from a local pharma rival

By Christian Wienberg and Bloomberg
December 13, 2023
Roche pushes to catch up to Novo Nordisk’s Wegovy with $3.1bn deal for obesity drugmaker Carmot
Finance

Roche pushes to catch up to Novo Nordisk’s Wegovy with $3.1bn deal for obesity drugmaker Carmot

By Paula Doenecke and Bloomberg
December 4, 2023
Weight loss drugs are all the rage.
Health

Pfizer rocked by failure of weight-loss pill set to compete with lucrative rivals Ozempic and Mounjaro

By Madison Muller and Bloomberg
December 1, 2023
Lars Fruergaard Jorgensen holding a microphone in one hand and paper flashcards in the other hand
Health

Wegovy maker Novo Nordisk could make prices flexible—without cutting them—to persuade more health systems to cover the weight-loss drugs

By
November 27, 2023
Obesity drugs in Ozempic, Wegovy and Mounjaro are trimming back the Thanksgiving ‘food orgy’
Health

Obesity drugs in Ozempic, Wegovy and Mounjaro are trimming back the Thanksgiving ‘food orgy’

By Jonel Aleccia and The Associated Press
November 20, 2023
So many Americans are using Novo Nordisk’s blockbuster weight loss-aiding Ozempic that Germany may ban exports of the drug
Retail

So many Americans are using Novo Nordisk’s blockbuster weight loss-aiding Ozempic that Germany may ban exports of the drug

By
November 16, 2023
a box of wegovy injectables
Retail

Scientists have discovered a new benefit to Novo Nordisk’s weight-loss drug Wegovy: It can cut heart-related deaths by 20%, drugmaker reports

By
November 13, 2023
Wegovy, an injectable prescription weight-loss medicine.
Health

A ‘game-changing’ study backs Wegovy use to cut heart attacks and strokes: ‘This is not just about weight and appearance’

By Madison Muller, Naomi Kresge and Bloomberg
November 11, 2023
Novo Nordisk faces first real test as Eli Lilly wins approval for a weight loss-aiding drug—and it’s nearly $300 cheaper than Wegovy
Retail

Novo Nordisk faces first real test as Eli Lilly wins approval for a weight loss-aiding drug—and it’s nearly $300 cheaper than Wegovy

By
November 9, 2023
Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.
Health

Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.

By
November 6, 2023
picture of four wegovy injections lined up
Health

Novo Nordisk isn’t alone: Sales of Ozempic rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze

By
November 3, 2023
Brands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.
Health

Brands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.

By
November 2, 2023
KitKat maker Nestlé working on ‘companion products’ for weight-loss-aiding drugs Ozempic and Wegovy in case shoppers start cutting calories

KitKat maker Nestlé working on ‘companion products’ for weight-loss-aiding drugs Ozempic and Wegovy in case shoppers start cutting calories

By
October 19, 2023
ozempic injection picture
Finance

Wall Street is now betting against restaurant stocks because of Novo Nordisk’s Ozempic and high interest rates

By
October 10, 2023

Most Popular